PaxMedica, Inc.
PXMD
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -54.84% | 2.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.74% | -15.87% | |||
| Operating Income | 18.74% | 15.87% | |||
| Income Before Tax | 18.83% | 37.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.83% | 37.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.83% | 37.62% | |||
| EBIT | 18.74% | 15.87% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 21.33% | 65.75% | |||
| Normalized Basic EPS | 21.37% | 67.65% | |||
| EPS Diluted | 21.68% | 65.62% | |||
| Normalized Diluted EPS | 21.37% | 67.65% | |||
| Average Basic Shares Outstanding | 3.20% | 82.14% | |||
| Average Diluted Shares Outstanding | 3.20% | 82.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||